Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver-a potential mechanism of central scar formation

Human Pathology

Volumn 40, Issue 2, 2009, Pages 181-188

  Sato, Yasunori ^a   Harada, Kenichi ^a   Ikeda, Hiroko ^a   Fijii, Takahiko ^a   Sasaki, Motoko ^a   Zen, Yoh ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Central scar; Focal nodular hyperplasia; Hepatic stellate cell; Hyperperfusion; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CENTRAL SCAR FORMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIVER HYPERPLASIA; LIVER PERFUSION; NODULAR HYPERPLASIA; OXIDATIVE STRESS; PROTEIN EXPRESSION; SCAR FORMATION; STELLATE CELL;

ADULT; DEOXYGUANOSINE; FEMALE; FOCAL NODULAR HYPERPLASIA; HEPATIC STELLATE CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149109425     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.04.024     Document Type: Article

References (29)

1. Nakanuma Y. Non-neoplastic nodular lesions in the liver. Pathol Int 45 (1995) 703-714
2. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22 (1995) 983-993
3. Bioulac-Sage P., Balabaud C., Bedossa P., et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46 (2007) 521-527
4. Wanless I.R., Mawdsley C., and Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5 (1985) 1194-1200
5. Bioulac-Sage P., Balabaud C., and Wanless I.R. Diagnosis of focal nodular hyperplasia. Not so easy. Am J Surg Pathol 25 (2001) 1322-1325
6. Paradis V., Benzekri A., Dargere D., et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126 (2004) 1323-1329
7. Bioulac-Sage P., Rebouissou S., Sa Cunha A., et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128 (2005) 1211-1218
8. Matsushita M., Hajiro K., Suzaki T., et al. Focal nodular hyperplasia of the liver without central scar. Dig Dis Sci 40 (1995) 2407-2410
9. Cherqui D., Rahmouni A., Charlotte F., et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22 (1995) 1674-1681
10. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23 (1999) 1441-1454
11. Shen Y.H., Fan J., Wu Z.Q., et al. Focal nodular hyperplasia of the liver in 86 patients. Hepatobiliary Pancreat Dis Int 6 (2007) 52-57
12. Brancatelli G., Federle M.P., Grazioli L., et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219 (2001) 61-68
13. Di Ilio C., Angeiucci S., Bucciarelli T., et al. Alteration of glutathione transferase subunits composition in the liver of young and aged rats submitted to hypoxic conditions. Biochem Biophys Acta 1312 (1996) 125-131
14. Miralles C., Busquets X., Santos C., et al. Redulation of iNOS expression and glutathione levels in rat by oxygen tension. FEBS Lett 476 (2000) 253-257
15. Schild L., Reinheckel T., Reiser M., et al. Nitric oxide produced in rat liver mitochondria causes oxidative stress and impairment of respiration after transient hypoxia. FASEB J 17 (2003) 2194-2201
16. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
17. Ijichi H., Taketomi A., Yoshizumi T., et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J Hepatol 45 (2006) 28-34
18. Ronco M.T., Frances D., de Lujan Alvarez M., et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci 81 (2007) 750-755
19. Yoshiji H., Kuriyama S., Yoshiji J., et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52 (2003) 1347-1354
20. Urso M.L., and Clarkson P.M. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 189 (2003) 41-54
21. Kaji K., Kaneko S., Matsushita E., et al. A case of progressive multiple focal nodular hyperplasia with alteration of imaging studies. Am J Gastroenterol 93 (1998) 2568-2572
22. Li J., and Billiar T.R. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276 (1999) G1069-G1073
23. Malleske D.T., Rogers L.K., Velluci S.M., et al. Hyperoxia increases hepatic arginase expression and ornithine production in mice. Toxicol Appl Pharmacol 215 (2006) 109-117
24. Prosser C.C., Yen R.D., and Wu J. Molecular therapy for hepatic injury and fibrosis: where are we?. World J Gastroenterol 12 (2006) 509-515
25. Ferrara N. Vascular endothelial growth factor: basic and clinical progress. Endocr Rev 25 (2004) 581-611
26. Tsurui Y., Sho M., Kuzumoto Y., et al. Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 79 (2005) 1110-1115
27. Osada S., Imai H., Tomita H., et al. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death. J Gastroenterol Hepatol 21 (2006) 988-993
28. Nakamura K., Zen Y., Sato Y., et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1a are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol 38 (2007) 1532-1546
29. Ohmoto K., Honda T., Hirokawa M., et al. Spontaneous regression of focal nodular hyperplasia of the liver. J Gastroenterol 37 (2002) 849-853